How Supplied:
0.05% gel, 1 x 60 g tube and 2 x 60 g twin pack
Indications and Usage:
DESONATE® (desonide) Gel, 0.05% is a corticosteroid indicated for topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.
Prescribing Instructions:
Prescribing Information Instructions [PDF]
Side Effects and Contraindications:
Local adverse reactions may include atrophy, striae, irritation, acneiform eruptions, hypopigmentation and allergic contact dermatitis and may be more likely with occlusive use or more potent corticosteroids. The most common adverse reactions (incidence ≥ 1%) are headache, application site burning and rash. Desonate is contraindicated in those with a history of hypersensitivity to any of the components of the preparation. Topical corticosteroids can produce reversible hypothalamic pituitary adrenal (HPA) axis suppression, Cushing's syndrome and unmask latent diabetes. Systemic absorption may require evaluation for HPA axis suppression. Modify use should HPA axis suppression develop. Potent corticosteroids, use on large areas, prolonged use or occlusive use may increase systemic absorption. Pediatric patients may be more susceptible to systemic toxicity when treated with topical corticosteroids due to their larger skin surface-to-body mass ratios. Unless directed by a physician, do not use on the underarm or groin area of children. Do not use to treat diaper dermatitis. Use in children less than three months of age is not recommended. Not for ophthalmic, oral or intravaginal use. As with other corticosteroids, therapy should be discontinued when control is achieved. Safety beyond four weeks has not been established.
Company:
Dermatology unit of Bayer HealthCare
866-463-3634
desonate.com
MyList
Drugs
